Catalyst Wire Dossier Catalyst Wire Dossier

WT1 TCR gene therapy

WT1-targeted TCR · Cell Medica Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WT1 TCR gene therapy, covering 2018-10-02 to 2018-10-02. Get the full timeline:

Most recent: Clinical Trial Update: WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study [Phase 1, Phase 2]

See pricing